Market Chameleon (Thu, 4-Dec 5:24 AM ET)
Business Wire (Thu, 4-Dec 10:00 AM ET)
Business Wire (Wed, 3-Dec 5:41 PM ET)
Business Wire (Wed, 3-Dec 3:31 PM ET)
Acadia Healthcare Updates PLGL Reserves Following Annual Actuarial Review, Lowers 2025 Guidance
Business Wire (Tue, 2-Dec 4:05 PM ET)
Acadia Healthcare to Participate in UBS 2025 Global Healthcare Conference
Business Wire (Mon, 10-Nov 11:24 AM ET)
Acadia Healthcare Lowers Outlook Despite Solid Q3 Revenue Growth and Strong Admissions Momentum
Market Chameleon (Thu, 6-Nov 2:55 AM ET)
Acadia Healthcare Reports Third Quarter 2025 Results
Business Wire (Wed, 5-Nov 4:05 PM ET)
Acadia Healthcare Announces Date for Third Quarter 2025 Earnings Release
Business Wire (Mon, 20-Oct 4:22 PM ET)
Acadia Healthcare Appoints Todd Young as Chief Financial Officer
Business Wire (Tue, 7-Oct 4:15 PM ET)
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The company's revenue is derived from services rendered to patients for inpatient psychiatric and substance abuse care, outpatient psychiatric care, and adolescent residential treatment.
Acadia Healthcare Company trades on the NASDAQ stock market under the symbol ACHC.
As of December 19, 2025, ACHC stock price declined to $14.41 with 2,874,546 million shares trading.
ACHC has a beta of 1.00, meaning it tends to be less sensitive to market movements. ACHC has a correlation of 0.09 to the broad based SPY ETF.
ACHC has a market cap of $1.30 billion. This is considered a Small Cap stock.
Last quarter Acadia Healthcare Company reported $852 million in Revenue and $.72 earnings per share. This beat revenue expectation by $1 million and exceeded earnings estimates by $.02.
In the last 3 years, ACHC traded as high as $87.77 and as low as $12.63.
The top ETF exchange traded funds that ACHC belongs to (by Net Assets): IJR, VTI, VB, VBR, VXF.
ACHC has underperformed the market in the last year with a price return of -63.1% while the SPY ETF gained +17.3%. ACHC has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -34.7% and -1.6%, respectively, while the SPY returned +3.3% and -0.6%, respectively.
ACHC support price is $13.85 and resistance is $15.01 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ACHC shares will trade within this expected range on the day.